Safety and Efficacy of Pharmacotherapy Containing the Second-Generation Integrase Inhibitors and Chemotherapy Drugs in AIDS-Related Diffuse Large B-Cell Lymphoma: A Single-Center Retrospective Analysis
Second-generation INSTIs seem to be a safe and effective first-line treatment option for AR-DLBCL patients undergoing chemotherapy, regardless of the chemotherapy type.
Authors
- Xingzhen Cheng
- Wei Guo (ORCID: https://orcid.org/0000-0001-6212-8390)
- Jing Yang (ORCID: https://orcid.org/0000-0001-5017-4867)
- Yong Zhao (ORCID: https://orcid.org/0000-0002-8976-5602)
- Tingyu Chen (ORCID: https://orcid.org/0009-0000-0092-0868)
Institutions
- Public Health Clinical Center of Chengdu (CN)
Publication Details
- Journal
- Oncology Research and Treatment
- Published
- 2025-04-03
- DOI
- https://doi.org/10.1159/000545644
- Primary Topic
- HIV/AIDS drug development and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00